# Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

> **NCT01262560** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 163 (actual)

## Conditions studied

- Dysphagia
- Lung Cancer
- Pain
- Esophagitis

## Interventions

- **DRUG:** Manuka honey in liquid form
- **DRUG:** Manuka honey in lozenge form
- **DRUG:** Standard supportive care

## Key facts

- **NCT ID:** NCT01262560
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-02
- **Final completion:** 2014-11
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2017-08-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01262560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01262560, "Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01262560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*